Publications by authors named "Jacob B Reibel"

Claim this Profile
R
Real-world impact of the platinum chemotherapy shortage on US patients with advanced cancer.
Jacob B Reibel, Lova L Sun, Ravi B Parikh, Nadim Mahmud, Lainie P Martin

J Natl Cancer Inst· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular disease and cancer: shared risk factors and mechanisms.
Nicholas S Wilcox, Uri Amit, Jacob B Reibel, Eva Berlin, Kendyl Howell

Nat Rev Cardiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed.
Christine A Ciunci, Jacob B Reibel, Tracey L Evans, Rosemarie Mick, Joshua M Bauml

Clin Lung Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.
Haikuo Zhang, Jun Qi, Jaime M Reyes, Lewyn Li, Prakash K Rao, Jacob B Reibel

Cancer Discov· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.
Chunxiao Xu, Christine M Fillmore, Shohei Koyama, Hongbo Wu, Yanqiu Zhao, Jacob B Reibel

Cancer Cell· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit.
Zehua Zhu, Amir R Aref, Travis J Cohoon, Thanh U Barbie, Yu Imamura, Jacob B Reibel

Cancer Discov· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance.
Zhao Chen, Esra Akbay, Oliver Mikse, Tanya Tupper, Katherine Cheng, Jacob B Reibel

Clin Cancer Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.
Esra A Akbay, Shohei Koyama, Julian Carretero, Abigail Altabef, Jeremy H Tchaicha, Jacob B Reibel

Cancer Discov· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis